GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
127 hedge funds and large institutions have $741M invested in Genomic Health, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 59 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
127
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$15.6M | |
| 2 | +$11.6M | |
| 3 | +$4.98M | |
| 4 |
Renaissance Technologies
New York
|
+$3.87M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.82M |
Top Sellers
| 1 | -$28.5M | |
| 2 | -$3.3M | |
| 3 | -$3.24M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.21M |
| 5 |
HH
HWG Holdings
Houston,
Texas
|
-$2.76M |